Chào mừng trở lại
Bấm vào "Đăng nhập " để đồng ý Điều khoản dịch vụ Cointime và xác nhận rằng Chính sách bảo mật Cointime là dành cho bạn.
Tham gia Cointime
Đã có tài khoản?
Bấm vào "Đăng nhập " để đồng ý Điều khoản dịch vụ Cointime và xác nhận rằng Chính sách bảo mật Cointime là dành cho bạn.
Đăng nhập với email
Đăng nhập với
Email của bạn
Đăng ký
Bấm vào liên kết chúng tôi gửi tới để đăng nhập
Nhấp vào liên kết chúng tôi đã gửi tới để đăng ký.
DCVC Bio
company
About
DCVC Bio is a venture capital fund that invests in early-stage life science companies driven by deep-tech approaches.
- 1 - 10
Highlights
Details
- Industries
- AgTech,Biotechnology,Life Science
- Founded date
- Jan 1, 2018
- Number Of Employee
- 1 - 10
- Operating Status
- Active
- Investor Type
- Venture Capital
DCVC Bio is a venture capital fund that invests in early-stage life science companies driven by deep-tech approaches. Advances in genetic sequencing, artificial intelligence, and automation are converging to transform existing life sciences technologies and speed the development of new ones. The firm is looking for companies affecting deep technological change in synthetic biology, medicine, and agriculture.DCVC Bio was founded in 2018 and is based in San Francisco, California, United States.
Investments
Number of Investments
Number of Lead Investments
6
5
DCVC Bio has made 6 investments. Their most recent investment was on
Nov 29, 2022, when Verdant Robotics raised $46.50M.
|
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|
|
Nov 29, 2022
Verdant Robotics
|
Series A | $46.50M | Agriculture | — |
|
Oct 13, 2020
MycoWorks
|
Series B | $45M | Advanced Materials | Yes |
|
Mar 23, 2020
AbCellera
|
Series A | $75M | Artificial Intelligence | Yes |
|
Feb 25, 2020
MycoWorks
|
Series A | $17M | Advanced Materials | Yes |
|
Dec 1, 2019
Alchemab Therapeutics
|
Seed | — | Biotechnology | Yes |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
